Target intelligence / Profile preview

Esophageal sensitivity

01

Overview

Esophageal sensitivity refers to the physiological process by which the esophagus perceives and responds to various stimuli, including chemical (acid, bile), mechanical (distension), and thermal triggers (Fass & Tougas, 2002). In healthy individuals, this sensitivity is part of normal visceral sensation; however, in conditions like gastroesophageal reflux disease (GERD) and functional esophageal disorders, patients often exhibit esophageal hypersensitivity (Aziz et al., 2016). This hypersensitivity involves an exaggerated response to normal or sub-threshold stimuli, often mediated by peripheral sensitization of nociceptors such as Transient Receptor Potential Vanilloid 1 (TRPV1) or Acid-Sensing Ion Channels (ASICs) and central sensitization within the spinal cord or brain (Yamashita et al., 2021). While not a single molecular target itself, esophageal sensitivity is a key clinical endpoint and physiological state targeted by various pharmacological interventions, including acid suppressants and visceral neuromodulators (Dickman et al., 2007). Understanding the pathways of esophageal nociception is crucial for treating non-cardiac chest pain and refractory heartburn (Knowles & Aziz, 2009).

Other names
Esophageal hypersensitivityVisceral hypersensitivity of the esophagusEsophageal nociceptionEsophageal sensory perception
02

Mechanism of action

Pharmacological management typically involves acid suppression to reduce chemical stimuli or the use of visceral neuromodulators to alter the processing of sensory information in the peripheral and central nervous systems.

03

Biological functions

Sensory perceptionNociceptionVisceral sensationSignal transduction
04

Disease associations

Gastroesophageal reflux disease (GERD)Functional heartburnNon-cardiac chest painHypersensitive esophagusEosinophilic esophagitis
05

Safety considerations

Side effects of tricyclic antidepressants (TCAs) such as sedation and dry mouthRisk of masking underlying malignancy or structural diseasePotential for long-term dependency on acid suppression therapyAdverse effects of GABA-ergic agents like dizziness
06

Interacting drugs

Omeprazole

5 more in the full profile.

07

Biomarkers

Esophageal pH-impedance monitoringBernstein test (Acid perfusion test)Esophageal manometryBalloon distension thresholdCortical evoked potentials

Beyond the preview

Go deeper on Esophageal sensitivity.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Esophageal sensitivity.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call